These associations are plausible considering the naturally limited life expectancy of older individuals, the longer survival for women of any age [4], and the experience with other NSCLC, including EGFR+ lung adenocarcinoma, in which a positive smoking history and worse clinical condition at baseline are also associated with inferior outcome [5-7]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.